The novel formulation of rizatriptan and meloxicam (Symbravo, Axome Therapeutics) is for the acute treatment of migraine with ...

Everything's disrupted.’ It's not quite that simple.” Author, executive advisor, and chief futurist at Futurist.com, Nikolas Badminton, talks healthcare in 2050.

Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...

The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.

The European Medicines Agency’s positive opinion for ivermectin-albendazole for treating soil-transmitted helminth infections ...

Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...

The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive (pneumococcal polysaccharide conjugate vaccine [21-valent]) intended to ...

New research showed some long COVID patients get symptom relief by taking an extended course of Paxlovid. Data are ...

A pilot trial will assess whether concentrated bone marrow aspirate can prevent inflammation and reduce postsurgery pain and ...

Increased menstrual blood loss can be hard to measure and may detract from a woman’s quality of life, but a range of ...

Thyroid disease is often missed in older adults because its symptoms overlap with those of “normal aging.” In this two-article series, we examine thyroid disorders in the elderly, beginning with ...

Emergency department (ED) clinicians face multiple barriers in initiating naltrexone for alcohol use disorder (AUD), including a lack of screening protocols and limited treatment awareness.